These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 31681332)
1. Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming. Gyukity-Sebestyén E; Harmati M; Dobra G; Németh IB; Mihály J; Zvara Á; Hunyadi-Gulyás É; Katona R; Nagy I; Horváth P; Bálind Á; Szkalisity Á; Kovács M; Pankotai T; Borsos B; Erdélyi M; Szegletes Z; Veréb ZJ; Buzás EI; Kemény L; Bíró T; Buzás K Front Immunol; 2019; 10():2459. PubMed ID: 31681332 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2. Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978 [TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci. de Araujo Farias V; O'Valle F; Serrano-Saenz S; Anderson P; Andrés E; López-Peñalver J; Tovar I; Nieto A; Santos A; Martín F; Expósito J; Oliver FJ; de Almodóvar JMR Mol Cancer; 2018 Aug; 17(1):122. PubMed ID: 30111323 [TBL] [Abstract][Full Text] [Related]
4. Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery. Hu T; Hu J Cell Cycle; 2019 Nov; 18(22):3085-3094. PubMed ID: 31544590 [TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069 [TBL] [Abstract][Full Text] [Related]
7. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952 [TBL] [Abstract][Full Text] [Related]
8. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Yi X; Wei X; Lv H; An Y; Li L; Lu P; Yang Y; Zhang Q; Yi H; Chen G Exp Cell Res; 2019 Oct; 383(2):111454. PubMed ID: 31170401 [TBL] [Abstract][Full Text] [Related]
9. Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells. Chang L; Gao H; Wang L; Wang N; Zhang S; Zhou X; Yang H Aging (Albany NY); 2021 Apr; 13(8):11808-11821. PubMed ID: 33883305 [TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stem cell derived exosomes inhibit the survival of human melanoma cells through modulating miR-138-5p/SOX4 pathway. Wang X; Cui Z; Zeng B; Qiong Z; Long Z Cancer Biomark; 2022; 34(4):533-543. PubMed ID: 35275523 [TBL] [Abstract][Full Text] [Related]
11. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647 [TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4. Luan W; Ding Y; Xi H; Ruan H; Lu F; Ma S; Wang J J Exp Clin Cancer Res; 2021 Mar; 40(1):107. PubMed ID: 33741023 [TBL] [Abstract][Full Text] [Related]
13. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Shang S; Wang J; Chen S; Tian R; Zeng H; Wang L; Xia M; Zhu H; Zuo C Cancer Med; 2019 Dec; 8(18):7728-7740. PubMed ID: 31642612 [TBL] [Abstract][Full Text] [Related]